Michele R. Erickson‐Johnson

Author

Also Known As

M Erickson-Johnson, M. Erickson-Johnson, M.R. Erickson-Johnson, Michele Erickson-Johnson, Michele Erickson‐Johnson, Michele R Erickson-Johnson, Michele R. Erickson-Johnson, Michele R. Erickson‐Johnson

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona WinnMed Mayo Clinic in Florida Sichuan University

About

Michele R. Erickson‐Johnson is an author at Mayo Clinic specializing in pathology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.9K
2	Engineering	1	1	60
3	Health Sciences	1	1	14
4	Natural Sciences	1	1	16
5	Biomolecular Engineering	1	1	60

Michele R. Erickson‐Johnson

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma Munir R. Tanas, Andrea Sboner, André M. Oliveira, Science Translational Medicine	2011	395
Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion Michele R. Erickson‐Johnson, Margaret M. Chou, Barbara R. Evers, Laboratory Investigation Nodular FasciitisTransient NeoplasiaHistopathologyPathologyMyh9-usp6 Gene Fusion	2011	394
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH Eunhee S. Yi, Jennifer M. Boland, Joseph J. Maleszewski, Journal of Thoracic Oncology OncologyOncogenic AgentAlk Gene RearrangementMedicinePathology	2011	261
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer Jeremy Chien, Julie Staub, Shou-Ih Hu, Oncogene MedicinePathologyGynecologyCancer BiologyTumor Suppressor	2004	173
Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma Ping Yang, Kimary Kulig, Jennifer M. Boland, Journal of Thoracic Oncology Tobacco ControlOncologyBronchial NeoplasmWorse Disease-free SurvivalMedicine	2011	137
Molecular Testing for Lipomatous Tumors: Critical Analysis and Test Recommendations Based on the Analysis of 405 Extremity-based Tumors Hongying Zhang, Michele R. Erickson‐Johnson, Xiaoke Wang, The American Journal of Surgical Pathology Test RecommendationsSurgical OncologyMolecular TestingPathologyDermatology	2010	126
Frequency and characterization of <i>HMGA2</i> and <i>HMGA1</i> rearrangements in mesenchymal tumors of the lower genital tract Fabíola Medeiros, Michele R. Erickson‐Johnson, Gary L. Keeney, Genes Chromosomes and Cancer	2007	87
Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans Jared J. Abbott, Michele R. Erickson‐Johnson, Antonio G. Nascimento, Modern Pathology Tumor BiologyCol1a1-pdgfb Genomic CopiesMalignant DiseaseDermatofibrosarcoma ProtuberansMedicine	2006	86
Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of “myositis ossificans-like lesions” are the early phases in the formation of soft-tissue aneurysmal bone cyst William R. Sukov, Marcello Fabiano de Franco, Michele R. Erickson‐Johnson, Skeletal Radiology Brown TumorSurgical PathologyHistopathologyPathologyEarly Phases	2008	80
Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma Michele R. Erickson‐Johnson, Amber R. Seys, Christopher W. Roth, Modern Pathology Tumoral PathologyOncologyEngineeringWell-differentiated LiposarcomaMedicine	2009	60

Page 1